Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,358,356
New position
Shares Held
11,958
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. AZN ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,819 | $11,790,531 | |
| 2 | JNJ |
Johnson & Johnson
|
29,338 | $7,171,380 | |
| 3 | ABBV |
AbbVie Inc.
|
25,838 | $5,619,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,670 | $3,087,844 | |
| 5 | AMGN |
Amgen Inc
|
8,271 | $2,910,151 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,745 | $2,891,230 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
11,958 | $2,358,356 | |
| 8 | GSK |
GSK plc
|
29,471 | $1,626,504 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,358,356 | 11,958 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||